INVO Bioscience, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
INVO Bioscience, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • INVO Bioscience, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 3.86M shares, a 367% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.86M +3.04M +367% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 2.62M -11.4M -81.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 2.49M +1.88M +310% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 2.47M -9.69M -79.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 827K -11.3M -93.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 14M +1.87M +15.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 609K -11.3M -94.9% Dec 31, 2022 10-K/A 2024-04-17
Q3 2022 12.2M +1.7M +16.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 12.1M +1.67M +16% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 12.1M +1.67M +16% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 11.9M +2.29M +23.8% Dec 31, 2021 10-K 2023-04-17
Q3 2021 10.5M +5.51M +111% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 10.5M +2.56M +32.4% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 10.4M -147M -93.4% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 9.64M +4.75M +97.3% Dec 31, 2020 10-K 2022-03-31
Q3 2020 4.95M -151M -96.8% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 7.9M -148M -94.9% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 158M +3.15M +2.04% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 4.88M -149M -96.8% Dec 31, 2019 10-K 2021-03-30
Q3 2019 156M +8.14M +5.52% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 156M +8.09M +5.49% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 155M +10.6M +7.38% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 154M +12.2M +8.56% Dec 31, 2018 10-K 2020-03-30
Q3 2018 147M +5.77M +4.08% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 147M +6.17M +4.37% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 144M +2.86M +2.03% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 142M +1.54M +1.09% Dec 31, 2017 10-K 2019-04-16
Q3 2017 142M +1.08M +0.77% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 141M +688K +0.49% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 141M +4.05M +2.95% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 141M +3.51M +2.56% Dec 31, 2016 10-K 2018-03-29
Q3 2016 141M +6.52M +4.86% Sep 30, 2016 10-Q 2017-09-05
Q2 2016 141M +7.52M +5.65% Jun 30, 2016 10-Q 2017-09-05
Q1 2016 137M +17.2M +14.4% Mar 31, 2016 10-Q 2017-09-05
Q4 2015 137M +17.4M +14.5% Dec 31, 2015 10-Q 2017-09-05
Q3 2015 134M +22.7M +20.4% Sep 30, 2015 10-K 2017-03-17
Q2 2015 133M +21.7M +19.5% Jun 30, 2015 10-K 2017-03-17
Q1 2015 120M +8.46M +7.59% Mar 31, 2015 10-K 2017-03-17
Q4 2014 120M +8.33M +7.48% Dec 31, 2014 10-K 2017-03-17
Q3 2014 111M +1.25M +1.14% Sep 30, 2014 10-K 2017-03-17
Q2 2014 111M +3M +2.77% Jun 30, 2014 10-K 2017-03-17
Q1 2014 111M +5.61M +5.3% Mar 31, 2014 10-K 2017-03-17
Q4 2013 111M +17.9M +19.1% Dec 31, 2013 10-K 2017-03-17
Q3 2013 110M +18.8M +20.6% Sep 30, 2013 10-K 2017-03-17
Q2 2013 108M +17.3M +19% Jun 30, 2013 10-K 2017-03-17
Q1 2013 106M +16M +17.8% Mar 31, 2013 10-K 2017-03-17
Q4 2012 93.5M +10.4M +12.5% Dec 31, 2012 10-K 2017-03-17
Q3 2012 91.4M +11.3M +14.1% Sep 30, 2012 10-K 2017-03-17
Q2 2012 91.1M +13.2M +16.9% Jun 30, 2012 10-K 2017-03-17
Q1 2012 89.8M Mar 31, 2012 10-K 2017-03-17
Q4 2011 83.1M +8.54M +11.5% Dec 31, 2011 10-K 2017-03-17
Q3 2011 80M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 77.9M Jun 30, 2011 10-Q 2011-08-22
Q4 2010 74.5M Dec 31, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.